Innovation Pharmaceuticals Inc (IPIX)

[loanranger]

"Instead of a placebo the other arm will receive treatment either Remdesivir, Favipiravir or convalescent plasma."


"The FDA provided feedback on clinical development plans for the evaluation of Brilacidin as a treatment for COVID-19. The Company is now incorporating this feedback and finalizing the trial protocol for its planned Phase 2, randomized, double-blind, placebo-controlled, multi-national study to evaluate the efficacy and safety of Brilacidin in hospitalized patients with COVID-19."
http://www.ipharminc.com/press-release/2020/11/2/innovation-pharmaceuticals-receives-pre-ind-response-from-fda-on-covid-19-trial


The most highly respected contributors here have a duty to also be the most careful.